Skip to main content

1-12 of 12 results for subject:Schizophrenia

Year X
2000

Type

House

Session

Month

Department

Member

More

Primary member

Answering member

Legislative stage

Legislation

Subject

More

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

That this House recognises that Standard One of the Department of Health's National Service Framework for Mental Health seeks to promote the social inclusion of people with mental health problems, and regrets that 20th Century Fox has not listened to concerns from a coalition of 13 national mental health organisations...

Primary sponsor
Lynne Jones (Labour)
Type
Early day motions
Date
19 December 2000
Reference
128
House
House of Commons

That this House welcomes the publication of the Zito Trust survey of UK health authorities, 'Are local NHS services for treating severe mental illness adequate?'; notes with concern the key findings that access to the most appropriate and effective treatments, such as the new generation of antipsychotic drugs with reduced...

Primary sponsor
Baroness Bottomley of Nettlestone (Conservative)
Type
Early day motions
Date
8 December 2000
Reference
66
House
House of Commons
Type
Select Committee reports (Government responses); Command papers
Notes
Received 23.10.00
Date
30 October 2000
Reference
Cm 4888
House
House of Commons

To ask the Secretary of State for Health, which district health authorities prescribe clozapine for schizophrenia; and how many schizophrenics receive the drug, broken down by health authority, in the United Kingdom. (Holding answer 17 July 2000). - Inc fact that no of schizophrenic patients receiving clozapine is not available.

Asked by
Vincent Cable (Liberal Democrat)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
19 July 2000
Reference
354 c230-1W; 130944
House
House of Commons

To ask the Secretary of State for Health, if NICE will investigate the effectiveness of clozapine as a standard treatment for psychiatric illness.

Asked by
Vincent Cable (Liberal Democrat)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
17 July 2000
Reference
354 c78W; 130943
House
House of Commons
1st supplementary on patients abandoning their medication and tackling side effects.
Asked by
Lord Williamson of Horton (Crossbench)
Oral questions - 1st Supplementary
Status
Answered
Date
13 July 2000
Reference
615 c367-8
House
House of Lords
Whether National Health Service arrangements for the care and treatment of patients with schizophrenia are adequate.
Asked by
Lord Williamson of Horton (Crossbench)
Oral questions - Lead
Status
Answered
Date
13 July 2000
Reference
615 c367-8
House
House of Lords
Answered by
Lord Hunt of Kings Heath (Labour)
Type
Oral answers to questions
Date
13 July 2000
Reference
615 c367-8
House
House of Lords
Answered by
Lord Hunt of Kings Heath (Labour)
Type
Oral answers to questions
Date
13 July 2000
Reference
615 c367-8
House
House of Lords

To ask the Secretary of State for the Home Department, if he will make it his policy that the planned research into the interaction of CS spray and anti-psychotic medication used in the treatment of schizophrenia will involve wide consultation with relevant service users, carers and voluntary organisations.

Asked by
Tom Brake (Liberal Democrat)
Answering body
Home Office
Type
Written questions
Status
Answered
Date
11 July 2000
Reference
353 c521W;353 c519W; 129586
House
House of Commons

To ask the Secretary of State for Social Security, what the success rate of applications for Disability Living Allowance has been for (a) schizophrenia sufferers, (b) all categories of people suffering from mental illness and (c) all applicants for each of the most recent five years for which figures are...

Asked by
Gordon Marsden (Labour)
Answering body
Department of Social Security
Type
Written questions
Status
Answered
Date
29 March 2000
Reference
347 c164W; 116514
House
House of Commons

To ask the Secretary of State for Health, what plans the Government has to investigate the extent to which people with mental health problems are able to obtain atypical antipsychotics; and what steps the Government will take to ensure that people with mental illness have access to the drugs most...

Asked by
Helen Clark (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
12 January 2000
Reference
103920; 342 c197W
House
House of Commons